We are live on ! Find out more
FLNA

Filana Therapeutics

145 hedge funds and large institutions have $291M invested in Filana Therapeutics in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 28

47% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $37.2M

1.72% more ownership

Funds ownership: 26.96%28.68% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 153145 (-8)

12% less capital invested

Capital invested by funds: $332M → $291M (-$41.4M)

29% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 24

Holders
145
Holders Change
-8
Holders Change %
-5.23%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
58
Reduced
28
Closed
24
Calls
$54.8M
Puts
$37.2M
Net Calls
+$17.6M
Net Calls Change
-$10.5M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
$1.4M +$459K +16,556 +40%
Millennium Management
27
Millennium Management
New York
$1.3M +$920K +33,190 +159%
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$1.27M +$21.6K +781 +2%
LPL Financial
29
LPL Financial
California
$1.25M +$269K +9,716 +23%
JP Morgan Chase
30
JP Morgan Chase
New York
$1.2M +$284K +10,242 +26%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$1.18M +$18.4K +665 +1%
Neuberger Berman Group
32
Neuberger Berman Group
New York
$1.16M +$4.27K +154 +0.3%
UBS AM
33
UBS AM
Illinois
$1.12M +$403K +14,542 +46%
CF
34
Cantor Fitzgerald
New York
$1.11M +$1.28M +46,200 New
CS
35
Credit Suisse
Switzerland
$1.08M +$75K +2,707 +6%
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$938K +$20.1K +727 +2%
AllianceBernstein
37
AllianceBernstein
Tennessee
$921K
Legal & General Group
38
Legal & General Group
United Kingdom
$895K +$70.3K +2,537 +7%
Ameriprise
39
Ameriprise
Minnesota
$791K +$701K +25,293 +338%
Barclays
40
Barclays
United Kingdom
$784K -$309K -11,155 -26%
Deutsche Bank
41
Deutsche Bank
Germany
$710K +$222K +8,006 +37%
AA
42
ALPS Advisors
Colorado
$663K -$22.3K -806 -3%
T. Rowe Price Associates
43
T. Rowe Price Associates
Maryland
$651K +$43.4K +1,566 +6%
IAA
44
Independent Advisor Alliance
North Carolina
$619K +$711K +25,650 New
Jane Street
45
Jane Street
New York
$520K +$352K +12,722 +144%
PA
46
Profund Advisors
Maryland
$506K +$581K +20,963 New
ASN
47
Advisory Services Network
Georgia
$493K +$266K +9,600 +88%
HWAM
48
Hennion & Walsh Asset Management
New Jersey
$488K +$95.1K +3,434 +20%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$478K -$216K -7,786 -28%
MIM
50
MetLife Investment Management
New Jersey
$476K

FLNA Hedge Fund Activity: Q1 2023 in Review

145 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2023, worth a combined $291M — down 12% from $332M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of FLNA and 17 opened new positions — a net loss of 7 holders — while 28 trimmed existing stakes and 58 added.

The largest buyer was Susquehanna International Group, adding an estimated $4.48M. The largest seller was Invesco, cutting an estimated $3.45M.

  • 145 institutional investors held Filana Therapeutics (FLNA) as of Q1 2023, down from 153 in Q4 2022.
  • Funds reported $291M of Filana Therapeutics stock for Q1 2023, down 12% quarter-over-quarter.
  • 17 funds opened new Filana Therapeutics positions in Q1 2023 and 24 closed out, a net change of -7 holders.
  • The largest Filana Therapeutics buyer in Q1 2023 was Susquehanna International Group, an estimated $4.48M added.
  • The largest Filana Therapeutics seller in Q1 2023 was Invesco, an estimated $3.45M sold.

Based on aggregated 13F filings for Q1 2023.